Naldini L - Search Results

1

A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors.

Manganini M, Serafini M, Bambacioni F, Casati C, Erba E, Follenzi A, Naldini L, Bernasconi S, Gaipa G, Rambaldi A, Biondi A, Golay J, Introna M. Manganini M, et al. Among authors: naldini l. Hum Gene Ther. 2002 Oct 10;13(15):1793-807. doi: 10.1089/104303402760372909. Hum Gene Ther. 2002. PMID: 12396613

2

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences.

Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. Follenzi A, et al. Among authors: naldini l. Nat Genet. 2000 Jun;25(2):217-22. doi: 10.1038/76095. Nat Genet. 2000. PMID: 10835641

3

Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.

Guenechea G, Gan OI, Inamitsu T, Dorrell C, Pereira DS, Kelly M, Naldini L, Dick JE. Guenechea G, et al. Among authors: naldini l. Mol Ther. 2000 Jun;1(6):566-73. doi: 10.1006/mthe.2000.0077. Mol Ther. 2000. PMID: 10933981 Free article.

4

A new-generation stable inducible packaging cell line for lentiviral vectors.

Farson D, Witt R, McGuinness R, Dull T, Kelly M, Song J, Radeke R, Bukovsky A, Consiglio A, Naldini L. Farson D, et al. Among authors: naldini l. Hum Gene Ther. 2001 May 20;12(8):981-97. doi: 10.1089/104303401750195935. Hum Gene Ther. 2001. PMID: 11387062

5

Development of lentiviral vectors for antiangiogenic gene delivery.

Shichinohe T, Bochner BH, Mizutani K, Nishida M, Hegerich-Gilliam S, Naldini L, Kasahara N. Shichinohe T, et al. Among authors: naldini l. Cancer Gene Ther. 2001 Nov;8(11):879-89. doi: 10.1038/sj.cgt.7700388. Cancer Gene Ther. 2001. PMID: 11773978

6

Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors.

Follenzi A, Sabatino G, Lombardo A, Boccaccio C, Naldini L. Follenzi A, et al. Among authors: naldini l. Hum Gene Ther. 2002 Jan 20;13(2):243-60. doi: 10.1089/10430340252769770. Hum Gene Ther. 2002. PMID: 11812281

7

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors.

Vigna E, Cavalieri S, Ailles L, Geuna M, Loew R, Bujard H, Naldini L. Vigna E, et al. Among authors: naldini l. Mol Ther. 2002 Mar;5(3):252-61. doi: 10.1006/mthe.2002.0542. Mol Ther. 2002. PMID: 11863414 Free article.

8

Generation of HIV-1 derived lentiviral vectors.

Follenzi A, Naldini L. Follenzi A, et al. Among authors: naldini l. Methods Enzymol. 2002;346:454-65. doi: 10.1016/s0076-6879(02)46071-5. Methods Enzymol. 2002. PMID: 11883085 No abstract available.

9

Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement.

Lotti F, Menguzzato E, Rossi C, Naldini L, Ailles L, Mavilio F, Ferrari G. Lotti F, et al. Among authors: naldini l. J Virol. 2002 Apr;76(8):3996-4007. doi: 10.1128/jvi.76.8.3996-4007.2002. J Virol. 2002. PMID: 11907239 Free PMC article.

10

HIV-based vectors. Preparation and use.

Follenzi A, Naldini L. Follenzi A, et al. Among authors: naldini l. Methods Mol Med. 2002;69:259-74. Methods Mol Med. 2002. PMID: 11987783 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters